Author

C. William Wester

Professor of Medicine, Vanderbilt University School of Medicine - Cited by 4,265 - HIV/AIDS - Implementation Science and Non-Communicable Diseases

Biography

Dr.C. William Wester is a professor of in the Department of Medicine / Division of Infectious Diseases, Co-Director Global Health Pathway (VUMC Internal Medicine Residency) Associate Director Global Health Faculty Development. His goal of research includes long-term HIV complications with a focus on HIV-associated kidney disease and implementation science in resource-limited settings of the world.
Title
Cited by
Year
CDC recommendations for hepatitis C screening among adults—United States, 2020
S Schillie, C Wester, M Osborne, L Wesolowski, AB RyersonMMWR Recommendations and Reports 69 (2), 1, 2020202
350
2020
Universal hepatitis B vaccination in adults aged 19–59 years: updated recommendations of the Advisory Committee on Immunization Practices—United States, 2022
MK Weng, M Doshani, MA Khan, S Frey, K Ault, KL Moore, EW Hall, ...American Journal of Transplantation 22 (6), 1714-1720, 2022202
62
2022
Decreases in hepatitis C testing and treatment during the COVID-19 pandemic
HW Kaufman, L Bull-Otterson, WA Meyer III, X Huang, M Doshani, ...American journal of preventive medicine 61 (3), 369-376, 2021202
47
2021
Hepatitis C testing among perinatally exposed infants
SM Lopata, E McNeer, JA Dudley, C Wester, WO Cooper, JG Carlucci, ...Pediatrics 145 (3), 2020202
32
2020
Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023
Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 23EE Conners, L Panagiotakopoulos, MG Hofmeister, PR Spradling, ...MMWR Recommendations and Reports 72 (1), 1, 232
20
2023
Vital signs: hepatitis C treatment among insured adults—United States, 2019–2020
WW Thompson, H Symum, A Sandul, N Gupta, P Patel, N Nelson, ...Morbidity and Mortality Weekly Report 71 (32), 1011, 2022202
18
2022
Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria
UJ Wudil, MH Aliyu, HL Prigmore, DJ Ingles, AA Ahonkhai, BM Musa, ...Kidney international 100 (1), 6-154, 2021202
14
2021
Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017
AM Parcesepe, K Lancaster, EJ Edelman, R DeBoni, J Ross, L Atwoli, ...PLoS One 15 (), e0237772, 2020202
8
2020
Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium
E Brazier, R Ajeh, F Maruri, B Musick, A Freeman, CW Wester, MP Lee, ...Journal of the International AIDS Society 25 (12), e26036, 2022202
8
2022
Using an established outbreak response plan and molecular epidemiology methods in an HIV transmission cluster investigation, Tennessee, January–June 2017
Using an established outbreak response plan and molecular epidemiology methods in an HIV transmission cluster investigation, Tennessee, January–June 201L Sizemore, MM Fill, SA Mathieson, J Black, M Brantley, K Cooper, ...Public Health Reports 135 (3), 329-333, 2020202
7
2020
Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia
DC Boettiger, MG Law, J Ross, BV Huy, BSL Heng, R Ditangco, ...Journal of virus eradication (1), 11-18, 2020202
6
2020
Hepatitis C virus testing during pregnancy after universal screening recommendations
HW Kaufman, A Osinubi, WA Meyer III, M Khan, X Huang, ...Obstetrics and Gynecology 140 (1), 99, 2022202
5
2022
Individual, community, and structural factors associated with linkage to HIV care among people diagnosed with HIV in Tennessee
AA Ahonkhai, PF Rebeiro, CA Jenkins, M Rickles, M Cook, DF Conserve, ...Plos one 17 (3), e026408, 2022202
5
2022
The V-BRCH Project: building clinical trial research capacity for HIV and noncommunicable diseases in Nigeria
MH Aliyu, MU Sani, DJ Ingles, FI Tsiga-Ahmed, BM Musa, CM Audet, ...Health Research Policy and Systems 19 (1), 1-10, 2021202
5
2021
Hepatitis C in pregnancy and the TiP-HepC registry
N Gupta, L Hiebert, PA Armstrong, C Wester, JW WardThe Lancet Gastroenterology & Hepatology 7 (7), 598-599, 2022202
4
2022
Global Disparities in Skin Cancer Services at HIV Treatment Centers across 29 Countries.
DE McMahon, A Semeere, M Laker-Oketta, H Byakwaga, C Mugglin, ...The Journal of Investigative Dermatology 11 (10), 2533-2536. e2, 2021202
4
2021
Pregnancy status, risk factors, and opportunities for referral to care among reproductive-aged women with newly reported chronic hepatitis C virus infection in Tennessee
C Oliver, J Black, S De Pont, L Sizemore, C WesterPublic Health Reports 135 (1), 90-96, 2020202
4
2020
Adherence to combination antiretroviral therapy among pregnant women enrolled in a HIV prevention program in rural North-central Nigeria
CL Calder, H O’Hara, M Tabatabai, CJ Maxwell, S Marryshow, ...International Journal of Maternal and Child Health and AIDS 9 (1), 81, 2020202
4
2020
Poor retention and care-related sex disparities among youth living with HIV in rural Mozambique
AA Ahonkhai, MH Aliyu, CM Audet, M Bravo, M Simmons, G Claquin, ...Plos one 16 (5), e0250921, 2021202
3
2021
Immunodeficiency at antiretroviral therapy start: five-year adult data (2012–2017) based on evolving national policies in rural Mozambique
F Arinze, W Gong, AF Green, C De Schacht, JG Carlucci, W Silva, ...AIDS Research and Human Retroviruses 6 (1), 9-47, 2020202
3
2020

Referred From: https://scholar.google.co.in/citations?user=-bCQXpoAAAAJ&hl=hi

Cited by
Citations 4265
h-index 36
i10-index 74
Recommended Journals
Open Access Journals